Schröder R, Martínez F, Nielsen H. "Method for the Synthesis of (R)-3-[1-(1-Acryloylpiperidin-3-yl)-4-amino-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-N-(4-isopropyl-5-methylphenyl)benzamide" [P]. European Patent, EP 3596431 A1, 2025-06-21.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2014, 795, 9986-10008.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2011, 1701, (8), 162-171.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of (R)-3-[1-(1-Acryloylpiperidin-3-yl)-4-amino-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-N-(4-isopropyl-5-methylphenyl)benzamide Using HRMS and NMR". J. Pharm. Biomed. Anal., 2013, 616, 8037-8066.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2024, 1339, 4160-4170.